Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Pediatric Clinical Trials Market Size study, By Phase (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Treatment Studies and Observational Studies), By Therapeutic Area (Respiratory Diseases, Infectious Diseases, Oncology, Diabetes and Other Therapeutic Areas), and Regional Forecasts 2022-2028

  • BIZ4983232
  • 200 Pages
  • June 2022
  • Healthcare
Download Sample    Get Discount   
 
Global Pediatric Clinical Trials Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Pediatric Clinical Trials refers to clinical trials that are designed and conducted specifically for children. Pediatric clinical trials are mainly conducted to study and treat different therapeutic areas in children such as respiratory diseases, infectious diseases, oncology, diabetes. The rising burden of chronic and infectious diseases in pediatric and increasing awareness towards pediatric clinical trials as well as recent funding activities towards pediatric clinical trials are factors that are accelerating the global market demand. For instance, according to American Academy of Pediatrics – as of 2020, around 10 million children and adolescents in the United States are affected by some form of chronic illness or disability. Furthermore, as per World Health Organization (WHO) estimates – as of 2021, every year around 400 000 children and adolescents of 0-19 years affected by cancer. The most prevalent types of childhood cancers include leukemias, brain cancers, lymphomas and solid tumours, such as neuroblastoma and Wilms tumours. Moreover, in high-income countries, more than 80% of children with cancer are cured. Whereas, in low- and middle-income countries (LMICs), only less than 30% are cured. However, recent funding activities from regulatory organizations are likely to influence the growth of pediatric clinical trials. For instance, in May 2022, Australian Government’s Medical Research Future Fund (MRFF) awarded grant of USD 11 million to Five University of Sydney researchers. This funding intended to improve clinical and health outcomes of children affected with juvenile idiopathic arthritis. Also, growing research & development investments by pharmaceutical players and increasing adoption contract research organizations are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, stringent government regulations and cumbersome approval processes impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Pediatric Clinical Trials Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing healthcare spending and presence of leading market players. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing pediatric population and surging penetration of Clinical research organization (CROs) in the region, would create lucrative growth prospects for the global Pediatric Clinical Trials Market across the Asia Pacific region.

Major market players included in this report are:

ICON plc

Syneos Health

Medpace, Inc.

PPD Inc.

Premier Research

LabCorp Drug Development

QPS Holdings.

Pfizer Inc.

The Emmes Company, LLC

IQVIA Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Phase

Phase I

Phase II

Phase III

Phase IV

By Study Design

Treatment Studies

Observational Studies

By Therapeutic Area

Respiratory Diseases

Infectious Diseases

Oncology

Diabetes

Other Therapeutic Areas

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020

Base year – 2021

Forecast period – 2022 to 2028

Target Audience of the Global Pediatric Clinical Trials Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)

1.2.1. Global Pediatric Clinical Trials Market, by Region, 2020-2028 (USD Million)

1.2.2. Global Pediatric Clinical Trials Market, by Phase, 2020-2028 (USD Million)

1.2.3. Global Pediatric Clinical Trials Market, by Study Design, 2020-2028 (USD Million)

1.2.4. Global Pediatric Clinical Trials Market, by Therapeutic Areas, 2020-2028 (USD Million)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Pediatric Clinical Trials Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Pediatric Clinical Trials Market Dynamics

3.1. Pediatric Clinical Trials Market Impact Analysis (2020-2028)

3.1.1. Market Drivers

3.1.1.1. Growing burden of chronic and infectious diseases in pediatric.

3.1.1.2. Increasing awareness towards pediatric clinical trials.

3.1.1.3. Recent funding activities towards pediatric clinical trials.

3.1.2. Market Challenges

3.1.2.1. Stringent government regulations and cumbersome approval processes.

3.1.3. Market Opportunities

3.1.3.1. Growing R&D investments by pharmaceutical players.

3.1.3.2. Increasing adoption contract research organizations.

Chapter 4. Global Pediatric Clinical Trials Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

4.5. Top investment opportunity

4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1.1. Assessment of the overall impact of COVID-19 on the industry

5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pediatric Clinical Trials Market, by Phase

6.1. Market Snapshot

6.2. Global Pediatric Clinical Trials Market by Phase, Performance - Potential Analysis

6.3. Global Pediatric Clinical Trials Market Estimates & Forecasts by Phase 2018-2028 (USD Million)

6.4. Pediatric Clinical Trials Market, Sub Segment Analysis

6.4.1. Phase I

6.4.2. Phase II

6.4.3. Phase III

6.4.4. Phase IV

Chapter 7. Global Pediatric Clinical Trials Market, by Study Design

7.1. Market Snapshot

7.2. Global Pediatric Clinical Trials Market by Study Design, Performance - Potential Analysis

7.3. Global Pediatric Clinical Trials Market Estimates & Forecasts by Study Design 2018-2028 (USD Million)

7.4. Pediatric Clinical Trials Market, Sub Segment Analysis

7.4.1. Treatment Studies

7.4.2. Observational Studies

Chapter 8. Global Pediatric Clinical Trials Market, by Therapeutic Areas

8.1. Market Snapshot

8.2. Global Pediatric Clinical Trials Market by Therapeutic Areas, Performance - Potential Analysis

8.3. Global Pediatric Clinical Trials Market Estimates & Forecasts by Therapeutic Areas 2018-2028 (USD Million)

8.4. Pediatric Clinical Trials Market, Sub Segment Analysis

8.4.1. Respiratory Diseases

8.4.2. Infectious Diseases

8.4.3. Oncology

8.4.4. Diabetes

8.4.5. Other Therapeutic Areas

Chapter 9. Global Pediatric Clinical Trials Market, Regional Analysis

9.1. Pediatric Clinical Trials Market, Regional Market Snapshot

9.2. North America Pediatric Clinical Trials Market

9.2.1. U.S. Pediatric Clinical Trials Market

9.2.1.1. Phase estimates & forecasts, 2018-2028

9.2.1.2. Study Design estimates & forecasts, 2018-2028

9.2.1.3. Therapeutic Areas estimates & forecasts, 2018-2028

9.2.2. Canada Pediatric Clinical Trials Market

9.3. Europe Pediatric Clinical Trials Market Snapshot

9.3.1. U.K. Pediatric Clinical Trials Market

9.3.2. Germany Pediatric Clinical Trials Market

9.3.3. France Pediatric Clinical Trials Market

9.3.4. Spain Pediatric Clinical Trials Market

9.3.5. Italy Pediatric Clinical Trials Market

9.3.6. Rest of Europe Pediatric Clinical Trials Market

9.4. Asia-Pacific Pediatric Clinical Trials Market Snapshot

9.4.1. China Pediatric Clinical Trials Market

9.4.2. India Pediatric Clinical Trials Market

9.4.3. Japan Pediatric Clinical Trials Market

9.4.4. Australia Pediatric Clinical Trials Market

9.4.5. South Korea Pediatric Clinical Trials Market

9.4.6. Rest of Asia Pacific Pediatric Clinical Trials Market

9.5. Latin America Pediatric Clinical Trials Market Snapshot

9.5.1. Brazil Pediatric Clinical Trials Market

9.5.2. Mexico Pediatric Clinical Trials Market

9.6. Rest of The World Pediatric Clinical Trials Market

Chapter 10. Competitive Intelligence

10.1. Top Market Strategies

10.2. Company Profiles

10.2.1. ICON plc

10.2.1.1. Key Information

10.2.1.2. Overview

10.2.1.3. Financial (Subject to Data Availability)

10.2.1.4. Product Summary

10.2.1.5. Recent Developments

10.2.2. Syneos Health

10.2.3. Medpace, Inc.

10.2.4. PPD Inc.

10.2.5. Premier Research

10.2.6. LabCorp Drug Development

10.2.7. QPS Holdings.

10.2.8. Pfizer Inc.

10.2.9. The Emmes Company, LLC

10.2.10. IQVIA Inc.

Chapter 11. Research Process

11.1. Research Process

11.1.1. Data Mining

11.1.2. Analysis

11.1.3. Market Estimation

11.1.4. Validation

11.1.5. Publishing

11.2. Research Attributes

11.3. Research Assumption

List of Tables

TABLE 1. Global Pediatric Clinical Trials Market, report scope

TABLE 2. Global Pediatric Clinical Trials Market estimates & forecasts by Region 2018-2028 (USD Million)

TABLE 3. Global Pediatric Clinical Trials Market estimates & forecasts by Phase 2018-2028 (USD Million)

TABLE 4. Global Pediatric Clinical Trials Market estimates & forecasts by Study Design 2018-2028 (USD Million)

TABLE 5. Global Pediatric Clinical Trials Market estimates & forecasts by Therapeutic Areas 2018-2028 (USD Million)

TABLE 6. Global Pediatric Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 7. Global Pediatric Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 8. Global Pediatric Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 9. Global Pediatric Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 10. Global Pediatric Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 11. Global Pediatric Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 12. Global Pediatric Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 13. Global Pediatric Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 14. Global Pediatric Clinical Trials Market by segment, estimates & forecasts, 2018-2028 (USD Million)

TABLE 15. Global Pediatric Clinical Trials Market by region, estimates & forecasts, 2018-2028 (USD Million)

TABLE 16. U.S. Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 17. U.S. Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 18. U.S. Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 19. Canada Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 20. Canada Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 21. Canada Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 22. UK Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 23. UK Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 24. UK Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 25. Germany Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 26. Germany Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 27. Germany Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 28. RoE Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 29. RoE Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 30. RoE Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 31. China Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 32. China Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 33. China Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 34. India Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 35. India Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 36. India Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 37. Japan Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 38. Japan Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 39. Japan Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 40. RoAPAC Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 41. RoAPAC Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 42. RoAPAC Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 43. Brazil Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 44. Brazil Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 45. Brazil Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 46. Mexico Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 47. Mexico Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 48. Mexico Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 49. RoLA Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 50. RoLA Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 51. RoLA Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 52. Row Pediatric Clinical Trials Market estimates & forecasts, 2018-2028 (USD Million)

TABLE 53. Row Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 54. Row Pediatric Clinical Trials Market estimates & forecasts by segment 2018-2028 (USD Million)

TABLE 55. List of secondary sources, used in the study of global Pediatric Clinical Trials Market

TABLE 56. List of primary sources, used in the study of global Pediatric Clinical Trials Market

TABLE 57. Years considered for the study

TABLE 58. Exchange rates considered

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370